Shares of Thyrocare Technologies Ltd ended at ₹649.20, up by ₹27.60, or 4.44%, on the BSE. Previous Post Glenmark Pharma US arm agrees to $15.28 million settlement with Humana over antitrust lawsuits Next Post NDR InvIT Trust files draft papers for ₹750-cr IPO Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
